Approval · Notice of Compliance 4169 · 1997
REZULIN: Notice of Compliance 4169
Issued May 9, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4169
- Date
- May 9, 1997
- Company
- Parke-Davis Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antidiabetic agent, insulin resistance reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REZULIN | 02231095 | — |
| REZULIN | 02231096 | — |
Medicinal ingredients
- TROGLITAZONE 200 MG per TAB
- TROGLITAZONE 400 MG per TAB